Cagent Vascular

Wayne, PA · Founded 2014 · Privately Held (backing)

Developer of an intravascular technology designed to treat diseased peripheral arteries. Cagent Vascular is based in Wayne, PA and was founded in 2014. Its last reported valuation was $80.7 million in Jan 2024. It has raised $73.2 million across 5 recorded rounds; the latest was a $24.5 million early-stage round in May 2026.

Last reported valuation
$80.7M
Oct 2026
Priced at
—
Total raised
$73.2M
Last round
Early Stage VC
May 2026

Who backs Cagent Vascular?

10 investors
InvestorType
Ben Franklin Technology Partners of Southeastern PennsylvaniaOther
BF BelmontFamily office
Balestier Investments—
Blue Ridge Medical.—
M&L Group—
Sectoral Asset Management—
Synergy Ventures—
The FSB Companies—
Trinity Capital (Phoenix)—
U.S. Venture Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cagent Vascular investors

10 investors are on record for Cagent Vascular, including Ben Franklin Technology Partners of Southeastern Pennsylvania, BF Belmont, Balestier Investments and Blue Ridge Medical.. The early-stage round in May 2026 drew 51 investors.

Free account
More of Cagent Vascular with a free account
  • ·Watch Cagent Vascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Cagent Vascular. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View